Compare NBTB & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTB | NEOG |
|---|---|---|
| Founded | 1856 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 1995 | 1995 |
| Metric | NBTB | NEOG |
|---|---|---|
| Price | $44.56 | $8.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $51.33 | $10.67 |
| AVG Volume (30 Days) | 230.9K | ★ 1.9M |
| Earning Date | 04-23-2026 | 04-09-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 12.12 | N/A |
| EPS | ★ 0.98 | 0.02 |
| Revenue | $182,952,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $16.82 | N/A |
| Revenue Next Year | $4.88 | N/A |
| P/E Ratio | ★ $45.95 | $431.25 |
| Revenue Growth | ★ 10.40 | N/A |
| 52 Week Low | $39.21 | $4.53 |
| 52 Week High | $46.92 | $11.43 |
| Indicator | NBTB | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 39.88 |
| Support Level | $41.66 | $8.24 |
| Resistance Level | $45.23 | $10.12 |
| Average True Range (ATR) | 1.08 | 0.36 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 68.98 | 19.86 |
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.